[Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically]
- PMID: 14619441
[Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically]
Abstract
Neuraminidase inhibitor has changed the treatment of influenza dramatically. The drug is effective for both influenza A and B whereas amantadine, another anti-influenzal agent, inhibits influenza A virus infection but not B. Neuraminidase inhibitor blocks the process of release of influenza virus from infected cells and inhibit the virus transmission to the neighboring cells. Neuraminidase inhibitor improves the symptoms of influenza and shortens the duration of illness. It is emphasized that this drug should be given within forty-eight hours after the onset, and it must be not noted that the possibility of the drug resistant virus although it is observed infrequently. Prophylactic use of the drug is also discussed.
Similar articles
-
[Neuraminidase inhibitor].Nihon Rinsho. 2000 Nov;58(11):2293-8. Nihon Rinsho. 2000. PMID: 11225320 Review. Japanese.
-
Neuraminidase inhibitors for treatment of influenza A and B infections.MMWR Recomm Rep. 1999 Dec 17;48(RR-14):1-9. MMWR Recomm Rep. 1999. PMID: 10632443
-
[Criteria for the use of anti-influenza agents].Nihon Rinsho. 2003 Nov;61(11):1963-6. Nihon Rinsho. 2003. PMID: 14619439 Review. Japanese.
-
[Zanamivir, oseltamivir].Nihon Rinsho. 2004 Dec;62 Suppl 12:445-7. Nihon Rinsho. 2004. PMID: 15658359 Review. Japanese. No abstract available.
-
[Antiviral agents for influenza].Nihon Rinsho. 2003 Feb;61 Suppl 2:798-803. Nihon Rinsho. 2003. PMID: 12722319 Review. Japanese. No abstract available.
Cited by
-
Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model.Sci Rep. 2017 Jun 23;7(1):4136. doi: 10.1038/s41598-017-04365-6. Sci Rep. 2017. PMID: 28646236 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical